Jade Therapeutics

Jade Therapeutics develops locally administered, polymer-based products designed to treat poorly-served ophthalmic indications.

Jade Therapeutics, Inc. develops ophthalmic sustained-release drug delivery platforms. The company focuses on the development of locally administered, sustained-release therapeutics that improve corneal healing following damage from disease or injury, and improve visual function and quality of life. Its product delivers recombinant human growth hormone, a well characterized biologic, that has healing properties via the activation and recruitment of key cells involved in the tissue-building process.